Back to Search
Start Over
[A case of effective chemotherapy using CAF followed by docetaxel for advanced breast cancer].
- Source :
-
Gan to kagaku ryoho. Cancer & chemotherapy [Gan To Kagaku Ryoho] 2000 Sep; Vol. 27 (10), pp. 1577-80. - Publication Year :
- 2000
-
Abstract
- A huge mass measuring 13 x 12 cm and wide cutaneous edema were detected in the right breast of a 51-year-old woman. Under a diagnosis of locally advanced breast cancer (T4bN2M1, stage IV) with liver metastases, we attempted sequential neoadjuvant chemotherapy. After three courses of CAF therapy (cyclophosphamide, doxorubicin (DXR), 5-FU), the primary tumor was decreased by 56% and the liver metastases had disappeared. A minor pathologic response was observed. Subsequently, three courses of docetaxel (TXT) administration were carried out. The primary tumor was then decreased by 75% and the axillary metastases had disappeared. Histopathological examination showed gross viable tumor cells in the residual tumor and positive axillary lymph nodes. The only toxic effect was nausea (grade 1) and no major adverse effects were observed. Neoadjuvant chemotherapy with sequential DXR followed by TXT is a useful treatment for locally advanced breast cancer.
- Subjects :
- Antineoplastic Combined Chemotherapy Protocols administration & dosage
Breast Neoplasms pathology
Cyclophosphamide administration & dosage
Docetaxel
Doxorubicin administration & dosage
Female
Fluorouracil administration & dosage
Humans
Liver Neoplasms drug therapy
Liver Neoplasms secondary
Lymphatic Metastasis
Middle Aged
Neoadjuvant Therapy
Antineoplastic Agents, Phytogenic administration & dosage
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Breast Neoplasms drug therapy
Paclitaxel administration & dosage
Paclitaxel analogs & derivatives
Taxoids
Subjects
Details
- Language :
- Japanese
- ISSN :
- 0385-0684
- Volume :
- 27
- Issue :
- 10
- Database :
- MEDLINE
- Journal :
- Gan to kagaku ryoho. Cancer & chemotherapy
- Publication Type :
- Academic Journal
- Accession number :
- 11016005